SPRIM Global Investments (SGI) is the corporate venture capital arm of SPRIM, founded in 2008 and headquartered in Singapore. The firm specializes in clinical-stage life sciences and pharma services, deploying strategic capital into biotech, medtech, and digital health companies.
Their most common stage is series-a (80% of deals). Average disclosed round size is $10.8M (across 3 rounds with reported amounts).
Portfolio
5
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Team
Elizabeth Wang
TrialCap, Director, Credit Structuring
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| EErVimmune | Series A | $19.8M | Jan 2026 |
| AAzaleavision | Series A | — | Apr 2025 |
| SSpexis AG | Seed | $2.5M | Aug 2023 |
 RegASK | Series A | $10M | Dec 2022 |
 Azalea Vision | Series A | — | — |
Top Co-Investors
Last updated: 8 September 2026